Literature DB >> 24471805

Hb A2-Konz [δ50(D1)Ser → Thr; HBD: c.151T > A]: a new δ chain hemoglobin variant characterized by mass spectrometry and high performance liquid chromatography.

Tchilabalo Dilezitoko Alayi1, Alain Van Dorsselaer, Thomas Epting, Emmanuel Bissé, Christine Schaeffer-Reiss.   

Abstract

We report a new slow-moving δ chain hemoglobin (Hb) variant, named Hb A2-Konz [δ50(D1)Ser → Thr; HBD: c.151T > A]. It was detected during simultaneous measurement of Hb A1C and Hb A2 by high resolution cation exchange high performance liquid chromatography (HPLC) using a PolyCATA column. Hb A2-Konz comprised 0.8% of total Hb. This new variant was identified by peptide mapping using nanoliquid chromatography electrospray ionization-tandem mass spectrometry (nanoLC-ESI-MS/MS) as a serine to threonine substitution at δ50(D1), indicating that the variant was due to a single base change at codon 51 (TCT > ACT) of the δ-globin gene. The new mutant is clinically silent but could lead to a misdiagnosis of β-thalassemia (β-thal) based on the level of Hb A2.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24471805     DOI: 10.3109/03630269.2014.880063

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  2 in total

1.  Hemoglobin Kirklareli (α H58L), a New Variant Associated with Iron Deficiency and Increased CO Binding.

Authors:  Emmanuel Bissé; Christine Schaeffer-Reiss; Alain Van Dorsselaer; Tchilabalo Dilezitoko Alayi; Thomas Epting; Karl Winkler; Andres S Benitez Cardenas; Jayashree Soman; Ivan Birukou; Premila P Samuel; John S Olson
Journal:  J Biol Chem       Date:  2016-12-23       Impact factor: 5.157

2.  Analysis of deletional hereditary persistence of fetal hemoglobin/δβ-thalassemia and δ-globin gene mutations in Southerwestern China.

Authors:  Jie Zhang; Yang Yang; Peng Li; Yuanlong Yan; Tao Lv; Tingting Zhao; Xiaohong Zeng; Dongmei Li; Xiaoyan Zhou; Hong Chen; Jie Su; Tonghua Yang; Jing He; Baosheng Zhu
Journal:  Mol Genet Genomic Med       Date:  2019-05-01       Impact factor: 2.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.